According to the GSK-3 hypothesis of AD, excessive GSK-3 activity is responsible for memory impairment, tau hyperphosphorylation, increased Aβ production, and microglia-mediated neuroinflammatory responses [201]. Here, MAPT is linked to Alzheimer disease.